Singapore, Aug. 11 -- Long-term diabetes management requires continuous blood glucose monitoring to detect abnormalities early and intervene in time. However, conventional fingertip blood sampling is both painful and inconvenient, while most continuous glucose monitoring (CGM) products currently available on the market rely on biological enzymes - requiring regular replacement, incurring higher costs, and demanding stringent storage conditions.

A research team at The Hong Kong Polytechnic University (PolyU) has developed an enzyme-free, wearable, acoustically readable microneedle patch "ARMPatch". Once applied to the skin, it can be read by a standard ultrasound probe to continuously reflect changes in blood glucose levels.

The patch is...